Skip to main content
logo
MEDICOX Co., Ltd. (KOSDAQ:054180)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,295.00
-270.00 (-10.53%)
At close: Jul 2, 2025

MEDICOX Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-10,582-11,895-21,435-34,427-42,619-23,935
Depreciation & Amortization
1,7291,7292,1032,9713,2722,209
Loss (Gain) From Sale of Assets
1,3831,3833,657-842.26-457.79-2,492
Asset Writedown & Restructuring Costs
--2,824179.254,302-
Loss (Gain) From Sale of Investments
1,0301,030488.0311,709266.112,510
Loss (Gain) on Equity Investments
2,7962,7962,3741,2849,0589,240
Provision & Write-off of Bad Debts
-280-280-454.73264.78171.54-0.04
Other Operating Activities
294.96722.542,03210,66417,4094,952
Change in Accounts Receivable
26.1326.13-859.06-674.73-1,194163.61
Change in Inventory
-124.49-124.49527.34-412.09-546.31-48.75
Change in Accounts Payable
618.71618.71553.38845.39-172.98361.12
Change in Unearned Revenue
----7.68-1.28-
Change in Other Net Operating Assets
1,821561.741,557-411.351,321-204.08
Operating Cash Flow
-1,287-3,432-6,633-8,892-9,156-7,244
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-814.31-774.02-366.46-447.75-3,700-1,563
Sale of Property, Plant & Equipment
7,8938,02863.98181.82257.2754.34
Cash Acquisitions
-----2,811-
Divestitures
---1,649--
Sale (Purchase) of Intangibles
---0.39-48.7-2,768-
Investment in Securities
2,9553,1363,372-13,776782.85-20,749
Other Investing Activities
-5,289-4,793-9362,796-3,435-933.61
Investing Cash Flow
5,0945,9871,469-10,340-15,502-23,959

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-2,07219,92611,50220,3743,500
Long-Term Debt Issued
--4,0604,03839,58622,170
Total Debt Issued
2,0062,07223,98615,54059,95925,670
Short-Term Debt Repaid
--8,576-7,894-8,439-23,455-7,000
Long-Term Debt Repaid
--3,855-12,503-1,993-13,641-21,140
Total Debt Repaid
-10,389-12,431-20,397-10,432-37,095-28,140
Net Debt Issued (Repaid)
-8,382-10,3583,5895,10822,864-2,470
Issuance of Common Stock
-6,959993.5612,955-34,090
Repurchase of Common Stock
-6.63-6.13---38.84-
Other Financing Activities
-1.46-1.46--0621.22633.17
Financing Cash Flow
-8,390-3,4064,58318,06323,44632,253

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Miscellaneous Cash Flow Adjustments
000-0-0
Net Cash Flow
-4,583-851.86-581.51-1,169-1,2121,051

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-2,101-4,206-7,000-9,340-12,855-8,807
Free Cash Flow Growth
------
Free Cash Flow Margin
-7.60%-14.94%-22.87%-34.75%-63.34%-50.47%
Free Cash Flow Per Share
-326.44-781.28-1824.53-4836.04-9129.83-9980.78
Levered Free Cash Flow
1,680290.54-10,313-15,363-10,629983.45
Unlevered Free Cash Flow
2,4211,198-8,870-12,895-8,9543,225

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
918.411,0701,453424.341,019871.64
Cash Income Tax Paid
--72.83127.1814.2560.694.73
Change in Working Capital
2,3421,0821,778-660.45-593.73271.89